Literature DB >> 1366836

Inclined sedimentation for selective retention of viable hybridomas in a continuous suspension bioreactor.

B C Batt1, R H Davis, D S Kompala.   

Abstract

The continuous separation of nonviable hybridoma cells from viable hybridoma cells by using a narrow rectangular channel that is inclined from the vertical has been investigated experimentally. The effectiveness of the settler in selectively retaining viable hybridomas in the bioreactor while permitting the removal of nonviable hybridomas has been shown to depend on the flow rate through the settler. Intermediate flow rates through the settler have been found to provide the highest removal of nonviable hybridomas relative to viable hybridoma retention. At high dilution rates through the chemostat, over 95% of the viable cells could be partitioned to the bottom of the settler while over 50% of the nonviable cells are removed through the top of the settler. This successful separation is due to the significantly larger size of the viable hybridomas than the nonviable ones. A continuous perfusion experiment was performed in which an external inclined settler was used to retain virtually all of the viable hybridomas in the culture, while selectively removing from the culture approximately 20% of the nonviable cells that entered the settler. A stable viable cell concentration of 1.0 x 10(7) cells/mL was achieved, as was an antibody productivity of over 50 micrograms/(mL.day). These represent 3- and 6-fold increases, respectively, over the values obtained from a chemostat culture without cell retention.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1366836     DOI: 10.1021/bp00006a600

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  16 in total

1.  A tubular segmented-flow bioreactor for the infection of insect cells with recombinant baculovirus.

Authors:  Y C Hu; M Y Wang; W E Bentley
Journal:  Cytotechnology       Date:  1997-07       Impact factor: 2.058

2.  Foreign protein expression from S phase specific promoters in continuous cultures of recombinant CHO cells.

Authors:  G G Banik; P W Todd; D S Kompala
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

3.  Long-term Continuous Production of Monoclonal Antibody by Hybridoma Cells Immobilized in a Fibrous-Bed Bioreactor.

Authors:  Hui Zhu; Shang-Tian Yang
Journal:  Cytotechnology       Date:  2004-01       Impact factor: 2.058

4.  Analysis of the use of fortified medium in continuous culture of mammalian cells.

Authors:  A Gambhir; C Zhang; A Europa; W S Hu
Journal:  Cytotechnology       Date:  1999-11       Impact factor: 2.058

5.  Fluid flow through a high cell density fluidized-bed during centrifugal bioreactor culture.

Authors:  Christopher J Detzel; Bernard J Van Wie; Cornelius F Ivory
Journal:  Biotechnol Prog       Date:  2010 Jul-Aug

Review 6.  Spiral microfluidic devices for cell separation and sorting in bioprocesses.

Authors:  N Herrmann; P Neubauer; M Birkholz
Journal:  Biomicrofluidics       Date:  2019-11-05       Impact factor: 2.800

7.  Enhanced antibody production associated with altered amino acid metabolism in a hybridoma high-density perfusion culture established by gravity separation.

Authors:  H A Hansen; B Damgaard; C Emborg
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

8.  Cell separations using targeted monoclonal antibodies against overproduced surface proteins.

Authors:  K R Tadikonda; R H Davis
Journal:  Appl Biochem Biotechnol       Date:  1994       Impact factor: 2.926

9.  A study of the Coriolis effect on the fluid flow profile in a centrifugal bioreactor.

Authors:  Christopher J Detzel; Michael R Thorson; Bernard J Van Wie; Cornelius F Ivory
Journal:  Biotechnol Prog       Date:  2009 Jul-Aug

10.  Kinetic simulation of a centrifugal bioreactor for high population density hybridoma culture.

Authors:  Christopher J Detzel; Derek J Mason; William C Davis; Bernard J van Wie
Journal:  Biotechnol Prog       Date:  2009 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.